183 related articles for article (PubMed ID: 17442207)
1. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
Kang XM; Zhang QY; Tong DD; Zhao W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.
Xu TM; Cui MH; Xin Y; Gu LP; Jiang X; Su MM; Wang DD; Wang WJ
Chin Med J (Engl); 2008 Aug; 121(15):1394-7. PubMed ID: 18959116
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
[TBL] [Abstract][Full Text] [Related]
6. [Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma].
Pan Z; Ye D; Xie X; Chen H; Lu W
Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):227-30. PubMed ID: 12133417
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma.
Zhang Q; Kang X; Zhao W
Biochem Biophys Res Commun; 2006 Apr; 342(3):824-8. PubMed ID: 16499874
[TBL] [Abstract][Full Text] [Related]
8. [Study of thalidomide on the growth and angiogenesis of ovary cancer SKOV3 transplanted subcutaneously in nude mice].
Li W; Peng ZL; Cao ZY
Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):186-9. PubMed ID: 15840315
[TBL] [Abstract][Full Text] [Related]
9. [Effect of ginsenoside Rg3 on the progression of orthotopically xenotransplanted human breast cancer in nude mice and its mechanism].
Chen D; Zhao Y; Bai S; Shi Z; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):546-8. PubMed ID: 12910717
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of insulin-like growth factor-1 (IGF-1) to angiogenesis of breast cancer in IGF-1-deficient mice].
Tang HB; Ren YP; Zhang J; Ma SH; Gao F; Wu YP
Ai Zheng; 2007 Nov; 26(11):1215-20. PubMed ID: 17991321
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo.
Yang LQ; Wang B; Gan H; Fu ST; Zhu XX; Wu ZN; Zhan DW; Gu RL; Dou GF; Meng ZY
Biopharm Drug Dispos; 2012 Nov; 33(8):425-36. PubMed ID: 22898996
[TBL] [Abstract][Full Text] [Related]
14. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.
Li W; Wan L; Zhai LY; Wang J
Int J Mol Sci; 2014 Oct; 15(10):19265-80. PubMed ID: 25342321
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice.
Zhang Q; Kang X; Yang B; Wang J; Yang F
Cancer Biother Radiopharm; 2008 Oct; 23(5):647-53. PubMed ID: 18999937
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside 20(S)‑Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells.
Li J; Liu T; Zhao L; Chen W; Hou H; Ye Z; Li X
Int J Oncol; 2015 Feb; 46(2):775-81. PubMed ID: 25405516
[TBL] [Abstract][Full Text] [Related]
17. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and EMT signalling pathways.
Zeng X; Liu S; Yang H; Jia M; Liu W; Zhu W
J Pharm Pharmacol; 2023 Nov; 75(11):1405-1417. PubMed ID: 37498992
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway.
Jiang JW; Chen XM; Chen XH; Zheng SS
World J Gastroenterol; 2011 Aug; 17(31):3605-13. PubMed ID: 21987607
[TBL] [Abstract][Full Text] [Related]
19. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
Li W; Xu RJ; Lin ZY; Zhuo GC; Zhang HH
Med Oncol; 2009; 26(2):170-7. PubMed ID: 18988002
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
